We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

90 hedge funds and large institutions have $174M invested in BioSpecifics Technologies Corp. in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 37 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 30

11% more capital invested

Capital invested by funds: $156M → $174M (+$17.4M)

0% more funds holding

Funds holding: 9090 (0)

0% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
90
Holders Change
Holders Change %
0%
% of All Funds
2.4%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
6
Increased
37
Reduced
30
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
51
New York State Common Retirement Fund
New York
$553K +$56.2K +1,400 +13%
California State Teachers Retirement System (CalSTRS)
52
California State Teachers Retirement System (CalSTRS)
California
$522K +$4.02K +100 +0.9%
CS
53
Credit Suisse
Switzerland
$495K +$22.8K +568 +6%
HIP
54
Hatteras Investment Partners
North Carolina
$489K -$361K -8,990 -46%
SGAM
55
Smith Group Asset Management
Texas
$461K +$9.64K +240 +2%
Asset Management One
56
Asset Management One
Japan
$428K
DCM
57
Dupont Capital Management
Delaware
$400K
CAM
58
ClariVest Asset Management
California
$384K +$4.02K +100 +1%
TA
59
Teachers Advisors
New York
$360K
ADEF
60
Adams Diversified Equity Fund
Maryland
$272K
UBS Group
61
UBS Group
Switzerland
$263K +$7.87K +196 +4%
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$244K +$8.84K +220 +4%
BFM
63
Boothbay Fund Management
New York
$238K +$209K +5,204 New
VKH
64
Virtu KCG Holdings
New York
$225K +$198K +4,937 New
SO
65
STRS Ohio
Ohio
$214K -$205K -5,100 -52%
TSS
66
Two Sigma Securities
New York
$209K +$184K +4,575 New
MLICM
67
Metropolitan Life Insurance Company (MetLife)
New York
$206K
AIM
68
Acrospire Investment Management
Illinois
$204K -$30.5K -759 -15%
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$197K +$8.79K +219 +5%
BG
70
BlackRock Group
United Kingdom
$194K
CCMH
71
Cornerstone Capital Management Holdings
New York
$177K +$12K +300 +8%
NFA
72
Nationwide Fund Advisors
Ohio
$163K
US Bancorp
73
US Bancorp
Minnesota
$158K +$17.9K +445 +15%
Citigroup
74
Citigroup
New York
$158K +$82.5K +2,053 +145%
AIG
75
American International Group
New York
$142K +$161 +4 +0.1%

BSTC Hedge Fund Activity: Q3 2016 in Review

90 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2016, worth a combined $174M — up 11% from $156M a quarter earlier.

Fund positioning in BSTC was balanced in Q3 2016: 6 funds opened new positions, 6 closed out, 37 added to existing stakes and 30 trimmed.

The largest buyer was Northpointe Capital, opening a new position worth an estimated $4.97M. The largest seller was RK Capital Management (Colorado), cutting an estimated $3.44M.

  • 90 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $174M of BioSpecifics Technologies Corp. stock for Q3 2016, up 11% quarter-over-quarter.
  • 6 funds opened new BioSpecifics Technologies Corp. positions in Q3 2016 and 6 closed out, a net change of 0 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2016 was Northpointe Capital, an estimated $4.97M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2016 was RK Capital Management (Colorado), an estimated $3.44M sold.

Based on aggregated 13F filings for Q3 2016.